COMPOSITIONS COMPRISING A PSILOCYBIN DERIVATIVE AND A CANNABINOID
申请人:CaaMTech, LLC
公开号:US20190142851A1
公开(公告)日:2019-05-16
This disclosure pertains to new compositions and methods comprising a psilocybin derivative. In one embodiment, the compositions disclosed herein are used for a method of regulating a neurotransmitter receptor, e.g., a serotonin receptor. In one embodiment, the compositions disclosed herein comprise purified compounds, e.g., a purified psilocybin derivative, a purified cannabinoid, or purified terpene.
COMPOSITIONS COMPRISING A SEROTONERGIC TRYPTAMINE COMPOUND
申请人:CAAMTECH, INC.
公开号:US20210346346A1
公开(公告)日:2021-11-11
Disclosed herein are compositions comprising a serotonergic tryptamine compound, combinations thereof, and methods of using them for treating and preventing a variety of human conditions. In one embodiment, disclosed herein are new compositions and methods which comprise a therapeutically effective amount of a first purified psilocybin derivative and a therapeutically effective amount of a second compound. The second compound is selected from the group consisting of a second purified psilocybin derivative, a purified terpene, a serotonergic drug, an adrenergic drug, a dopaminergic drug, a purified erinacine, and a purified hericenone.